Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Aizenstein, 2008, Frequent amyloid deposition without significant cognitive impairment among the elderly, Arch Neurol, 65, 1509, 10.1001/archneur.65.11.1509

American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, DSM-IV

Andreasen, 1999, Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset alzheimer disease and stability during the course of disease, Arch Neurol, 56, 673, 10.1001/archneur.56.6.673

Archer, 2006, Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study, Ann Neurol, 60, 145, 10.1002/ana.20889

Bacskai, 2007, Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report, Arch Neurol, 64, 431, 10.1001/archneur.64.3.431

Bennett, 2005, Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions, Neurology, 64, 834, 10.1212/01.WNL.0000152982.47274.9E

Bobinski, 2000, The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease, Neuroscience, 95, 721, 10.1016/S0306-4522(99)00476-5

Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, 82, 239, 10.1007/BF00308809

Carlson, 2008, Trajectories of brain loss in aging and the development of cognitive impairment, Neurology, 70, 828, 10.1212/01.wnl.0000280577.43413.d9

Chan, 2003, Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study, Lancet, 362, 1121, 10.1016/S0140-6736(03)14469-8

Clark, 2003, Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?, Arch Neurol, 60, 1696, 10.1001/archneur.60.12.1696

Csernansky, 2004, Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects, Alzheimer Dis Assoc Disord|, 18, 190

Leon, 2006, Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment, Neurobiol Aging, 27, 394, 10.1016/j.neurobiolaging.2005.07.003

Drzezga, 2008, Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease, Neuroimage, 39, 619, 10.1016/j.neuroimage.2007.09.020

Edison, 2007, Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study, Neurology, 68, 501, 10.1212/01.wnl.0000244749.20056.d4

Engelborghs, 2007, No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease, Brain, 130, 2320, 10.1093/brain/awm136

Engler, 2006, Two-year follow-up of amyloid deposition in patients with Alzheimer's disease, Brain, 129, 2856, 10.1093/brain/awl178

Fagan, 2006, Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans, Ann Neurol, 59, 512, 10.1002/ana.20730

Fagan, 2007, Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults, Arch Neurol, 64, 343, 10.1001/archneur.64.3.noc60123

Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Forsberg, 2008, PET imaging of amyloid deposition in patients with mild cognitive impairment, Neurobiol Aging, 29, 1456, 10.1016/j.neurobiolaging.2007.03.029

Fox, 2000, Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects, Arch Neurol, 57, 339, 10.1001/archneur.57.3.339

Freeborough, 1997, The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI, IEEE Trans Med Imaging, 16, 623, 10.1109/42.640753

Gomperts, 2008, Imaging amyloid deposition in Lewy body diseases, Neurology, 71, 903, 10.1212/01.wnl.0000326146.60732.d6

Gosche, 2002, Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study, Neurology, 58, 1476, 10.1212/WNL.58.10.1476

Gunter, 2003, Methodological considerations for measuring rates of brain atrophy, J Magn Reson Imaging, 18, 16, 10.1002/jmri.10325

Hampel, 2004, Core biological marker candidates of Alzheimer's disease – perspectives for diagnosis, prediction of outcome and reflection of biological activity, J Neural Transm, 111, 247, 10.1007/s00702-003-0065-z

Hansson, 2006, Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study, Lancet Neurol, 5, 228, 10.1016/S1474-4422(06)70355-6

Ikonomovic, 2008, Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease, Brain, 131, 1630, 10.1093/brain/awn016

Ingelsson, 2004, Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, 62, 925, 10.1212/01.WNL.0000115115.98960.37

Jack, 2008, The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods, J Magn Reson Imaging, 27, 685, 10.1002/jmri.21049

Jack, 2002, Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia, Neurology, 58, 750, 10.1212/WNL.58.5.750

Jack, 2008, 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment, Brain, 131, 665, 10.1093/brain/awm336

Jack, 1992, MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease, Neurology, 42, 183, 10.1212/WNL.42.1.183

Jack, 2000, Rates of hippocampal atrophy correlate with change in clinical status in aging and AD, Neurology, 55, 484, 10.1212/WNL.55.4.484

Jack, 2004, Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD, Neurology, 62, 591, 10.1212/01.WNL.0000110315.26026.EF

Jack, 2005, Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI, Neurology, 65, 1227, 10.1212/01.wnl.0000180958.22678.91

Jack, 1989, Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults, Radiology, 172, 549, 10.1148/radiology.172.2.2748838

Jack, 2008, Atrophy rates accelerate in amnestic mild cognitive impairment, Neurology, 70, 1740, 10.1212/01.wnl.0000281688.77598.35

Jagust, 2008, Neuropathological basis of magnetic resonance images in aging and dementia, Ann Neurol, 63, 72, 10.1002/ana.21296

Jicha, 2006, Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia, Arch Neurol, 63, 674, 10.1001/archneur.63.5.674

Johnson, 2007, Imaging of amyloid burden and distribution in cerebral amyloid angiopathy, Ann Neurol, 62, 229, 10.1002/ana.21164

Jovicich, 2006, Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data, Neuroimage, 30, 436, 10.1016/j.neuroimage.2005.09.046

Kemppainen, 2007, PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment, Neurology, 68, 1603, 10.1212/01.wnl.0000260969.94695.56

Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009

Kokmen, 1991, The short test of mental status. Correlations with standardized psychometric testing, Arch Neurol, 48, 725, 10.1001/archneur.1991.00530190071018

Leinonen, 2008, Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B, Arch Neurol, 65, 1304, 10.1001/archneur.65.10.noc80013

Li, 2008, Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease, Eur J Nucl Med Mol Imaging, 35, 2169, 10.1007/s00259-008-0833-y

Lockhart, 2007, PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis, Brain, 130, 2607, 10.1093/brain/awm191

Lopresti, 2005, Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis, J Nucl Med, 46, 1959

Mathis, 2003, Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents, J Med Chem, 46, 2740, 10.1021/jm030026b

McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Mintun, 2006, [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease, Neurology, 67, 446, 10.1212/01.wnl.0000228230.26044.a4

Mormino, 2008, Episodic memory loss is related to hippocampal-mediated {beta}-amyloid deposition in elderly subjects, Brain

Morris, 1993, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a

Nordberg, 2004, PET imaging of amyloid in Alzheimer's; disease, Lancet Neurol, 3, 519, 10.1016/S1474-4422(04)00853-1

O’Brien, 1983, The appropriateness of analysis of variance and multiple-comparison procedures, Biometrics, 39, 787, 10.2307/2531110

Perneger, 1998, What's wrong with Bonferroni adjustments, Bmj, 316, 1236, 10.1136/bmj.316.7139.1236

Petersen, 2001, Current concepts in mild cognitive impairment, Arch Neurol, 58, 1985, 10.1001/archneur.58.12.1985

Pike, 2007, Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease, Brain, 130, 2837, 10.1093/brain/awm238

Rabinovici, 2007, 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration, Neurology, 68, 1205, 10.1212/01.wnl.0000259035.98480.ed

Raji, 2008, Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B, J Neurosci Methods, 172, 277, 10.1016/j.jneumeth.2008.05.005

Ridha, 2006, Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study, Lancet Neurol, 5, 828, 10.1016/S1474-4422(06)70550-6

Rowe, 2007, Imaging beta-amyloid burden in aging and dementia, Neurology, 68, 1718, 10.1212/01.wnl.0000261919.22630.ea

Schneider, 2007, Mixed brain pathologies account for most dementia cases in community-dwelling older persons, Neurology, 69, 2197, 10.1212/01.wnl.0000271090.28148.24

Senjem, 2008, Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases, Alzheimer's Dementia, 4

Silbert, 2003, Changes in premorbid brain volume predict Alzheimer's disease pathology, Neurology, 61, 487, 10.1212/01.WNL.0000079053.77227.14

Sled, 1998, A nonparametric method for automatic correction of intensity nonuniformity in MRI data, IEEE Trans Med Imaging, 17, 87, 10.1109/42.668698

Sluimer, 2008, Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study, Neurobiol Aging

Sojkova, 2008, Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?, J Nucl Med, 49, 1465, 10.2967/jnumed.108.051946

Tang-Wai, 2003, Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment, Arch Neurol, 60, 1777, 10.1001/archneur.60.12.1777

Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410

Tzourio-Mazoyer, 2002, Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain, Neuroimage, 15, 273, 10.1006/nimg.2001.0978

Vemuri, 2008, Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage, Neuroimage, 42, 559, 10.1016/j.neuroimage.2008.05.012

Villemagne, 2008, Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease, Neuropsychologia, 46, 1688, 10.1016/j.neuropsychologia.2008.02.008

Wahlund, 2003, Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients, Neurosci Lett, 339, 99, 10.1016/S0304-3940(02)01483-0

Whitwell, 2007, Rates of cerebral atrophy differ in different degenerative pathologies, Brain, 130, 1148, 10.1093/brain/awm021

Whitwell, 2008, MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study, Neurology, 71, 743, 10.1212/01.wnl.0000324924.91351.7d

Zarow, 2005, Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia, Ann Neurol, 57, 896, 10.1002/ana.20503